| 111 |
Reliability ,Validity,and Senesitivty to change Overtime of the modified Melasmsa Area and Severity index Score. |
2017 |
| 112 |
Reliability ,Validity,and Senesitivty to change Overtime of the modified Melasmsa Area and Severity index Score. |
2017 |
| 113 |
Serum IL-17 in patients with erythema multiforme or Stevens– Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity |
2017 |
| 114 |
Serum IL-17 in patients with erythema multiforme or Stevens– Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity |
2017 |
| 115 |
Serum IL-17 in patients with erythema multiforme or Stevens– Johnson syndrome/toxic epidermal necrolysis drug reaction, and correlation with disease severity |
2017 |
| 116 |
Serum level of interleukin-22 in patients with psoriasis and its correlation with disease severity |
2017 |
| 117 |
Serum level of interleukin-22 in patients with psoriasis and its correlation with disease severity |
2017 |
| 118 |
Serum level of interleukin-22 in patients with psoriasis and its correlation with disease severity |
2017 |
| 119 |
Serum levels of Adiponectin and Visfatin in patients with lichen planus: Case-controlled study
|
2017 |
| 120 |
Suppression of transforming growth factor-beta1 expression in keloids after cryosurgery |
2017 |
هل لديك سؤال ؟
